US Probes Germany
The U.S. said the probe will examine whether "persistent underpayment" for medicines by Germany is discriminatory. "President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development," said U.S. Trade Representative Jamieson Greer. Germany has proposed overhauling its health insurance system to reduce pressure on public finances. The U.S. has launched an investigation into Germany's pharma policies over what it referred to as "persistent underpayment" for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs. "President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development," said U.S. Trade Representative Jamieson Greer in a statement late Thursday. "I am par...
S. said the probe will examine whether "persistent underpayment" for medicines by Germany is discriminatory. S. Trade Representative Jamieson Greer.
Germany has proposed overhauling its health insurance system to reduce pressure on public finances. S. has launched an investigation into Germany's pharma policies over what it referred to as "persistent underpayment" for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs. S.
Trade Representative Jamieson Greer in a statement late Thursday. " In April, Germany proposed overhauling its health insurance system to reduce pressure on public finances, as health spending has increased substantially in recent years. It introduced a range of cost-saving measures, including higher discounts for insurance funds from the pharma industry, prompting numerous drugmaker executives to warn that they might withdraw or delay new medicines in the country. The draft legislation is currently going through parliamentary processes.
S. S. commerce. S.
trading partners must pay their fair share to fund research into new medicines, and that the investigations come after months of discussion with German partners. S. to lower ones abroad. The German Health Ministry didn't immediately respond to a request for comment.